id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-003974-cr6omr9l	Rutter, Sara	How do we … integrate pathogen reduced platelets into our hospital blood bank inventory?	2019-03-18		.txt	text/plain	5355	271	46	Initial methods included screening donors for travel histories to banned areas and for high-risk behaviors, but pathogen-specific assays performed at the collection and manufacturing sites also have become key factors in assuring blood safety. In recent years, the Food and Drug Administration has approved rapid tests to identify bacterially contaminated PLT units in the blood bank before transfusion. In recent years, the Food and Drug Administration has approved rapid tests to identify bacterially contaminated PLT units in the blood bank before transfusion. Pathogen reduction (PR) of platelet (PLT) concentrates using a psoralen as the photoactivating agent is a relatively new Food and Drug Administration (FDA)-approved technology that has been deemed suitable by the Agency for all patient demographics. Thus, after receipt of a request for PLTs, either a PR unit or a conventional non-PR unit (the latter tested with the PGD assay if stored for 5 days before distribution), would be issued by the blood bank staff as equivalent products without concern for patient acuity or demographics.	./cache/cord-003974-cr6omr9l.txt	./txt/cord-003974-cr6omr9l.txt